Local release of interleukin-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti-inflammatory activity and results in a delayed tumor rejection

European Cytokine Network

Volumn 9, Issue 1, 1998, Pages 61-68

  Di Carlo, Emma ^a   Coletti, Anna ^b   Modesti, Andrea ^b   Giovarelli, Mirella ^c   Forni, Guido ^c   Musiani, Piero ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Angiogenesis; Cytokines; Endothelial adhesion molecules; Interleukin 10; Tumor rejection

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; COMPLEMENTARY DNA; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD VESSEL INJURY; BREAST ADENOCARCINOMA; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA TRANSFECTION; ENDOTHELIUM CELL; FEMALE; GENETIC ENGINEERING; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; TUMOR CELL; TUMOR GROWTH; TUMOR REGRESSION;

ADENOCARCINOMA; ANIMALS; ANTI-INFLAMMATORY AGENTS; FEMALE; GENE EXPRESSION; GRAFT REJECTION; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RECOMBINANT PROTEINS; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA;

EID: 0031971930     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. De Waal-Malefyt R, Yssel H, Roncarolo M G, Spits H, de Vries J E. 1992. Interleukin-10. (Review) Curr. Opin. Immunol. 4: 314.
2. De Waal-Malefyt R, Abrams J, Bennet B, Figdor C G, de Vries J E. 1991. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209.
3. Fiorentino D F, Zlotnik A, Mosmann T R, Howard M, O'Garra A. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol 147: 3815.
4. Bogdan C, Vodovotz Y, Nathan C F. 1991. Macrophage deactivation by interleukin-10. J. Exp. Med. 174: 1549.
5. Oswald I P, Wynn T A, Sher A, James S L. 1992. Interleukin-10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor-alpha required as a costimulatory factor for interferon-gamma induced activation. Proc. Natl. Acad. Sci. USA 89: 8676.
6. Fiorentino D F, Bond M W, Mosmann T R. 1989. Two types of mouse T helper cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170: 2081.
7. Howard M, O' Garra A. 1992. Biological properties of interleukin-10. (Review) Immunol. Today 13: 198.
8. Li L, Elliott J F, Mosmann T R. 1994. IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersenstivity. J. Immunol. 153: 3967.
9. Vieira P, de Waal-Malefyt R, Dang M N, Johnson K E, Kastelein R, Fiorentino D F, de Vries J E, Roncarolo M G, Mosmann T R, Moore K W. 1991. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRF1. Proc. Natl. Acad. Sci. USA. 88: 1172.
10. Del Prete G, De Carli M, Almerigogna F, Giudizi M G, Biagiotti R, Romagnani S. 1993. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150: 353.
11. Hsu D H, Moore K W, Spits H. 1992. Differential effects of interleukin-4 and -10 on interleukin -2 induced interferon-γ synthesis and lymphokine-activated killer activity. Int. Immunol. 4: 563.
12. Katsikis P D, Chu C Q, Brennan F M, Maini R N, Feldmann M. 1994. Immunoregulatory role of interleukin-10 in rheumatoid arthritis. J. Exp. Med. 179: 1517.
13. Pajkrt D, Camoglio L, Tiel-van Buul M C, de Bruin K, Cutler D L, Affrime M B, Rikken G, van der Poll T, ten Cate JW, van Deventer S J. 1997. Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration. J. Immunol. 158: 3971.
14. Gerard C, Bruyns C, Marchant A, Abramowicz, D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, Velu T. 1993. Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177: 547.
15. Howard M, Muchamuel T, Andrade S, Menon S. 1993. Interleukin-10 protects mice from lethal endotoxemia. J. Exp. Med. 177: 1205.
16. Richter G, Kruger-Krasagakes S, Hein G, Huls C, Schmitt E, Diamantstein T, Blankstein T. 1993. Interleukin-10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res. 53: 4134.
17. Allione A, Consalvo M, Nanni P, Lollini P L, Cavallo F, Giovarelli M, Forni M, Gulino A, Colombo M P, Dellabona P, Hock H, Blankenstein T, Rosenthal F M, Gansbacher B, Colombo M C, Musso T, Gusella L, Forni G. 1994. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with IL-2, IL-4, IL-6, IL-7, IL-10, TNF-α, GM-CSF, and IFN-γ gene or admixed with conventional adjuvants. Cancer Res. 54: 6022.
18. Giovarelli M, Musiani P, Modesti A, Dellabona P, Casorati G, Allione A, Consalvo M, Cavallo F, di Pierro F, De Giovanni C, Musso T, Forni G. 1995. Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances anti-tumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory. J. Immunol. 155: 3112.
19. Musiani P, Allione A, Modica A, Lollini PL, Giovarelli M, Cavallo F, Belardelli F, Forni G, Modesti A. 1996. Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-α, IFN-γ, and TNF-α. Lab. Invest. 74: 146.
20. Berman R M, Suzuki T, Tahara H, Robbins P D, Narula S K, Lotze M T. 1996. Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice. J. Immunol. 157: 231.
21. Kundu N, Beaty T L, Jackson M J, Fulton A M. 1996. Anti-metastatic and anti-tumor activities of interleukin-10 in a murine model of breast cancer. J. Natl. Cancer Inst. 88: 536.
22. Gerard C M, Bruyns C, Delvaux A, Baudson N, Dargent J L, Goldman M, Velu T. 1996. Loss tumorigenicity and increased immunogenicity induced by interleukin-10 gene transfer in B16 melanoma cells. Hum. Gene Ther. 7: 23.
23. Nanni P, De Giovanni C, Lollini P L, Nicoletti G, Prodi G. 1983. A new metastasizing cell line forms a BALB/c spontaneous mammary adenocarcinoma. Clin. Exp. Metastasis 1: 373.
24. Yamamura M, Modlin R L, Ohmen J D, Moy R L. 1993. Local expression of anti-inflammatory cytokines in cancer. J. Clin. Invest. 91: 1005.
25. Kim J, Modlin R L, Moy R L, Dubinett S M, McHugh T, Nickoloff B J, Uyemura K. 1995. IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. J. Immunol. 155: 2240.
26. Young M R, Wright M A, Lozano Y, Matthews J P, Benefield J B, Prechel M M. 1996. Mechanisms of immune suppression in patients with head and neck cancer: influence on the immune infiltrate of the cancer. Int. J. Cancer 67: 333.
27. Cavallo F, Signorelli P, Giovarelli M, Musiani P, Modesti A, Brunda M J, Colombo M P, Forni G. 1997. Anti-tumor efficacy of adenocarcinoma cells engineered to produce interleukin-12 (IL-12) or other cytokines compared with exogenous IL-12. J. Natl. Cancer Inst. 89: 1049.
28. Pober J S, Cotran R S. 1990. The role of endothelial cells in inflammation. (Review) Transplantation 50: 537.
29. Vora M, Romero L I, Karasek M A. 1996. Interleukin-10 induces E-selectin on small and large blood vessel endothelial cells. J. Exp. Med. 184: 821.
30. Wogensen L, Huang X, Sarvetnick N. 1993. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin-10 in the islets of Langerhans. J. Exp. Med. 178: 175.
31. Koedel U, Bernatowicz A, Frei K, Fontana A, Pfister H W. 1996. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologie alterations in experimental pneumococcal meningitis. J. Immunol. 157: 5185.
32. Sironi M, Munoz C, Pollicino T, Siboni A, Sciacca F L, Bernasconi S, Vecchi A, Colotta F, Mantovani A. 1993. Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells. Eur. J. Immunol. 23: 2692.
33. Perretti M, Szabo C, Thiemermann. 1995. Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse. Br. J. Pharmacol. 116: 2251.
34. Corradin S B., Fasel N, Buchmuller-Rouiller Y, Ransijn A, Smith J, Mauel J. 1993. Induction of macrophage nitric oxide production by interferon-γ and tumor necrosis factor-α is enhanced by interleukin-10. Eur. J. Immunol. 23: 2045.
35. Chesrown S E, Monnier J, Visner G, Nick H S. 1994. Regulation of inducible nitric oxide synthase mRNA levels by LPS. IFN-α, TGF-β, and IL-10 in murine macrophage cell lines and rat peritoneal macrophages. Biochem. Biophys. Res. Commun 200: 126.
36. Lundberg J O, Lundberg J M, Alving K., Weitzberg E. 1997. Nitric oxide and inflammation: the answer is blowing in the wind. (Review) Nature Med. 3: 30.
37. Westlin W F, Gimbrone M A Jr. 1993. Neutrophil-mediated damage to human vascular endothelium. Role of cytokine activation. Am. J. Pathol. 142: 117.